Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Tau Medical Ltd. (DRTS : NSDQ)

• Company Description    Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. Alpha Tau Medical Ltd., formerly known as Healthcare Capital Corp., is based in JERUSALEM. Number of Employees: 121

• Price / Volume Information    Yesterday's Closing Price: $10.04 Daily Weekly Monthly 20 Day Moving Average: 963,645 shares Shares Outstanding: 88.01 (millions) Market Capitalization: $883.62 (millions) Beta: 1.11 52 Week High: $11.62 52 Week Low: $2.81 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 25.81% 19.67% 12 Week 26.61% 17.04% Year To Date 102.83% 103.57%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL KIRYAT HAMADA 5 - JERUSALEM,L3 9777605 ISR ph: 972-3577-4115 fax: - ir@alphatau.com http://www.alphatau.com

• General Corporate Information    Officers Uzi Sofer - Chief Executive Officer; Chairman and Director Amnon Gat - Chief Operations Officer Raphi Levy - Chief Financial Officer Michael Avruch - Director Ruth Alon - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: M0740A108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 88.01 Most Recent Split Date: (:1) Beta: 1.11 Market Capitalization: $883.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 12.74 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -116.67% vs. Previous Quarter: -85.71% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -73.23 12/31/25 - -57.29 09/30/25 - -56.45 ROA 03/31/26 - -52.90 12/31/25 - -42.39 09/30/25 - -41.76 Current Ratio 03/31/26 - 7.79 12/31/25 - 7.45 09/30/25 - 8.43 Quick Ratio 03/31/26 - - 12/31/25 - 7.45 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 0.79 12/31/25 - 0.88 09/30/25 - 0.91 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.09 12/31/25 - 0.08 09/30/25 - 0.08 Debt-to-Capital 03/31/26 - 8.45 12/31/25 - 7.61 09/30/25 - 7.35

Powered by Zacks Investment Research ©